Top Markets
Coin of the day
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Classement en actions #16729
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Prix de l'action
$3.78
Dernière synchronisation: 2026-03-17
Capitalisation boursière
$276.54M
Changement (1 jour)
0.00%
Changement (1 an)
45.53%
Pays
CA
Échange NervGen Pharma Corp. (NGEN)

Catégorie

Historique des divisions d’actions pour NervGen Pharma Corp. (NGEN)
L’action NervGen Pharma Corp. (symbole : NGEN) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Sep 02, 2026.
Une action NGEN achetée avant le Sep 02, 2026 équivaudrait aujourd’hui à 0 actions NGEN.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH